Arctoris

Arctoris

Private
AbingdonHealthcare & Life Scienceshttps://www.arctoris.com/

Last Round

Grant

May 1, 2020

Total Funding Raised

$4.03M

Company Overview

Arctoris is a biotechnology research company that operates an automated drug discovery platform using robotics and artificial intelligence to accelerate the development of new drugs.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Industrial Robotics, Medical AI, Workflow Automation

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS, Data as a Service

AI Layer

Application

Keywords

automated drug discoverylab automationcloud labrobotic labcontract research organizationCROdrug discovery servicesexperiments-as-a-servicelab as a serviceAI-ready datapartnership research organisationPROrobotics platformreproducible databiologics discoverybiochemistry servicescell biology services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arctoris Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Arctoris Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantMay 1, 2020
SeedSep 30, 2019

Key People

Founding team and executive leadership

Paul Custance

Chief Financial Officer, Financial Director

Executive Team

DPhil Poppy Roworth

Chief Operating Officer

Executive Team

Arctoris Investors

Notable investors and investment history

InvestorRounds
TanarraSeed
Innovate UKGrant
TD VeenSeed
Formic VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 22, 2025

    Grew 20% QoQ, from 35 to 42 employees.

  • Oct 26, 2024

    Monthly visitors grew 60% MoM, reaching 1.6K.

Arctoris Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Arctoris Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Arctoris's valuation, stock price, and market status.

Firmographic Details

HeadquartersAbingdon
Employee Range43
Year Founded2016
Last FundingMay 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.